RECTAL DYSPLASIA

This adverse event was reported 28 times

These drugs are most commonly taken by patients reporting RECTAL DYSPLASIA:

# Drug Count
0 ADALIMUMAB 13
1 VEDOLIZUMAB 9
2 ADALIMUMAB-AATY 8
3 ADALIMUMAB-ADAZ 8
4 ADALIMUMAB-FKJP 8
5 AZATHIOPRINE 7
6 MESALAMINE 5
7 METHOTREXATE 5
8 METHOTREXATE SODIUM 5
9 PREDNISOLONE 5
See all common drugs associated with RECTAL DYSPLASIA

RECTAL DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NEOSTIGMINE METHYLSULFATE 1 0.0023
1 ETRASIMOD 1 0.0006
2 REMIFENTANIL HYDROCHLORIDE 1 0.0004
3 SUGAMMADEX 1 0.0004
4 GOLIMUMAB 4 0.0003
5 MESALAMINE 5 0.0002
6 ADALIMUMAB-FKJP 8 0.0002
7 ADALIMUMAB-AATY 8 0.0002
8 ADALIMUMAB-ADAZ 8 0.0001
9 OFLOXACIN OTIC SOLUTION 1 0.0001
See all drugs enriched for association with RECTAL DYSPLASIA

RECTAL DYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Integrin Receptor Antagonist [EPC] 9 0.0001
1 Quinolone Antimicrobial [EPC] 1 0.0001
2 Purine Antimetabolite [EPC] 7 0.0001
3 Aminosalicylate [EPC] 6 0.0001
4 Provitamin D2 Compound [EPC] 1 0.0000
5 Interleukin-23 Antagonist [EPC] 3 0.0000
6 Folate Analog [EPC] 1 0.0000
7 Vitamin A [EPC] 1 0.0000
8 Interleukin-12 Antagonist [EPC] 2 0.0000
9 Nicotinic Acid [EPC] 1 0.0000
See all drug classes enriched for association with RECTAL DYSPLASIA